News Release
You can select the year, month, and category you wish to view.
- All
- Business Development
- Drug Discovery
- General Meeting of Shareholders
- Financial Information
- Other
-
2026.08.05
Announcement of a Lecture by Our CEO, Tohru Mizushima, at University of Fukui
(265KB)
-
2026.07.30
Notice Regarding the Signing of an Option Agreement with APOGEPHA
(149KB)
-
2026.07.10
Announcement Regarding the Publication of a Paper on the PC-SOD Phase III Clinical Trial Protocol
(169KB)
-
2026.07.07
Announcement of the Completion of Patient Enrollment in the Phase III Clinical Trial (Confirmatory Trial) for PC-SOD
(262KB)
-
2026.07.06
Report on participation in Bio2026
(479KB)
-
2026.06.29
Notice of Resolutions of the 24th Ordinary General Meeting of Shareholders
(96KB)
-
2026.04.07
Announcement of Joint Research Agreement with Kansai Medical University
(146KB)
-
2026.03.12
Notice of Initiation of Phase III Clinical Trial (Physician-Initiated Trial) for LT-5001 in Trigeminal Neuralgia
(254KB)
-
2026.03.10
Request for notification of changes to shareholder register entries, such as address changes
(251KB)
-
2026.03.09
Announcement of Completion of Investigational Drug Administration in the Phase IIa Clinical Trial of PC-SOD
(264KB)
